Work

PBI46 Cost-Effectiveness of Treatment Sequences Initiating with Risankizumab for the Treatment of Moderate to Severe Psoriasis in Portugal

Year: 2020

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2020.08.124

Authors: C. Carvalho, M. Batista, P. Ferreira, M. Henrique, S. Magina, M.J. Paiva Lopes, M. Placido, T. Torres, S. Vargas, J. Canilho

Institutions: AbbVie (Portugal), Hospital CUF Descobertas, Centro Hospitalar Leiria EPE, Hospital de São João, Hospital Santo António dos Capuchos, Exigo Consultores (Portugal), Centro Hospitalar do Porto

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3110696447

Cites:

Cited by: 1

Related to: 10